X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (631) 631
index medicus (618) 618
malaria (603) 603
artemether-lumefantrine (597) 597
infectious diseases (386) 386
female (380) 380
male (351) 351
tropical medicine (337) 337
antimalarials - therapeutic use (327) 327
parasitology (322) 322
parasitic diseases (306) 306
malaria, falciparum - drug therapy (303) 303
research (291) 291
child, preschool (273) 273
antimalarials - administration & dosage (271) 271
drug combinations (268) 268
plasmodium falciparum (248) 248
artemisinins - therapeutic use (245) 245
adult (242) 242
child (237) 237
artemisinins - administration & dosage (230) 230
infant (222) 222
malaria - drug therapy (222) 222
children (219) 219
drug therapy (211) 211
adolescent (207) 207
plasmodium-falciparum malaria (205) 205
antimalarials (200) 200
drug resistance (191) 191
drug therapy, combination (178) 178
animals (173) 173
lumefantrine (165) 165
treatment outcome (164) 164
efficacy (159) 159
infectious and parasitic diseases (159) 159
plasmodium falciparum - drug effects (158) 158
artemisinin (154) 154
artemether (151) 151
artesunate (151) 151
arctic medicine. tropical medicine (146) 146
health aspects (145) 145
middle aged (145) 145
pharmacology & pharmacy (142) 142
parasites (138) 138
young adult (138) 138
care and treatment (135) 135
antimalarials - adverse effects (132) 132
sulfadoxine-pyrimethamine (130) 130
dihydroartemisinin-piperaquine (126) 126
fluorenes - therapeutic use (123) 123
malaria, falciparum - parasitology (123) 123
analysis (122) 122
fluorenes - administration & dosage (121) 121
vector-borne diseases (121) 121
antimalarials - pharmacokinetics (120) 120
antimalarials - pharmacology (120) 120
drugs (117) 117
ethanolamines - therapeutic use (115) 115
uncomplicated malaria (115) 115
ethanolamines - administration & dosage (114) 114
public health (112) 112
dosage and administration (110) 110
artemisinins - adverse effects (109) 109
chloroquine (100) 100
pharmacokinetics (96) 96
studies (95) 95
amodiaquine (92) 92
clinical trials (87) 87
combination therapy (87) 87
plasmodium-falciparum (87) 87
safety (87) 87
drug dosages (86) 86
medicine (86) 86
plasmodium falciparum - genetics (86) 86
public, environmental & occupational health (84) 84
pregnancy (80) 80
resistance (80) 80
medical research (79) 79
microbiology (79) 79
infections (78) 78
mefloquine (76) 76
aged (75) 75
artemisinins - pharmacokinetics (75) 75
malaria, falciparum - epidemiology (75) 75
usage (74) 74
polymerase chain reaction (69) 69
population pharmacokinetics (66) 66
africa (65) 65
erythrocytes (65) 65
plasmodium falciparum - isolation & purification (65) 65
artemisinins - pharmacology (64) 64
fluorenes - pharmacokinetics (64) 64
patients (63) 63
therapy (63) 63
human diseases (62) 62
research article (62) 62
risk factors (62) 62
transmission (62) 62
ethanolamines - pharmacokinetics (61) 61
mortality (61) 61
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2018, Volume 2018, Issue 2, p. CD008152
Background The 8-aminoquinoline (8AQ) drugs act on Plasmodium falciparum gametocytes, which transmit malaria from infected people to mosquitoes. In 2012, the... 
45 MG PRIMAQUINE | ARTEMETHER-LUMEFANTRINE | SULFADOXINE-PYRIMETHAMINE | Artemisinins [administration & dosage; therapeutic use] | Quinine [therapeutic use] | Plasmodium falciparum [drug effects] | Malaria, Falciparum [parasitology; prevention & control; transmission] | LOW-DOSE PRIMAQUINE | GAMETOCYTOCIDAL ACTIVITY | Primaquine [administration & dosage] | Glucosephosphate Dehydrogenase Deficiency [diagnosis] | SPORONTOCIDAL TREATMENT | Randomized Controlled Trials as Topic | MEDICINE, GENERAL & INTERNAL | Sulfadoxine [administration & dosage] | MALARIA CONTROL | DIHYDROARTEMISININ-PIPERAQUINE | THERAPEUTIC-EFFICACY | Pyrimethamine [administration & dosage] | ARTESUNATE-MEFLOQUINE | Antimalarials [administration & dosage] | Mefloquine [therapeutic use] | Drug Combinations | Chloroquine [therapeutic use] | Malaria, Falciparum - prevention & control | Humans | Artemisinins - administration & dosage | Sulfadoxine - administration & dosage | Chloroquine - therapeutic use | Plasmodium falciparum - drug effects | Primaquine - administration & dosage | Glucosephosphate Dehydrogenase Deficiency - diagnosis | Malaria, Falciparum - parasitology | Malaria, Falciparum - transmission | Quinine - therapeutic use | Primaquine - analogs & derivatives | Artemisinins - therapeutic use | Mefloquine - therapeutic use | Antimalarials - administration & dosage | Pyrimethamine - administration & dosage | Time Factors | Mefloquine - administration & dosage | Non-Randomized Controlled Trials as Topic | Adult | Chloroquine - administration & dosage | Child
Journal Article
by Landier, Jordi and Parker, Daniel M and Thu, Aung Myint and Lwin, Khine Shwe War and Lwin, Khin Maung and Delmas, Gilles and Nosten, Suphak and Nosten, François H and Andolina, Chiara and Aguas, Ricardo and Ang, Saw Moe and Aung, Ei Phyo and Baw, Naw Baw and Be, Saw Aye and B'Let, Saw and Bluh, Hay and Bonnington, Craig A and Chaumeau, Victor and Chirakiratinant, Miasa and Cho, Win Cho and Christensen, Peter and Corbel, Vincent and Day, Nicholas PJ and Dah, Saw Hsa and Dhorda, Mehul and Dondorp, Arjen M and Gaudart, Jean and Gornsawun, Gornpan and Haohankhunnatham, Warat and Hla, Saw Kyaw and Hsel, Saw Nay and Htoo, Gay Nay and Htoo, Saw Nay and Imwong, Mallika and John, Saw and Kajeechiwa, Ladda and Kereecharoen, Lily and Kittiphanakun, Praphan and Kittitawee, Keerati and Konghahong, Kamonchanok and Khin, Saw Diamond and Kyaw, Saw Win and Ling, Clare and Ma, Naw K' Yin and Marie, Alexandra and Maung, Cynthia and Marta, Ed and Minh, Myo Chit and Miotto, Olivo and Moo, Paw Khu and Moo, Merry and Moo, Ku Ler and Na, Naw Na and Nay, Mar and Nyo, Slight Naw and Oh, Eh Kalu Shwe and Oo, Tun Pyit and Oo, Phu Thit and Paw, Eh Shee and Phumiya, Choochai and Phyo, Aung Pyae and Pilaseng, Kasiha and Proux, Stéphane and Rakthinthong, Santisuk and Ritwongsakul, Wannee and Salathibuphha, Kloloi and Santirad, Armon and Sawasdichai, Sunisa and von Seidlein, Lorenz and Shee, Paw Bway and Shee, Paw Wah and Tangseefa, Decha and Thwin, May Myo and Tun, Saw Win and Wanachaloemlep, Chode and White, Lisa J and White, Nicholas J and Wiladphaingern, Jacher and Win, Saw Nyunt and Yee, Nan Lin and Yuwapan, Daraporn and Malaria Elimination Task Force Grp and Malaria Elimination Task Force Group
The Lancet, ISSN 0140-6736, 05/2018, Volume 391, Issue 10133, pp. 1916 - 1926
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 04/2015, Volume 79, Issue 4, pp. 636 - 649
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2019, Volume 69, Issue 2, pp. 278 - 286
Background. Mass drug administration (MDA) may further reduce malaria transmission in low-transmission areas. The impact of MDA on the dynamics of malaria... 
INFECTIOUS DISEASES | mass drug administration | dihydroartemisinin-piperaquine | clinical malaria | gametocytes | FALCIPARUM | ARTEMETHER-LUMEFANTRINE | PLASMODIUM | MICROBIOLOGY | malaria infection | IMMUNOLOGY | CHILDREN | and Commentaries
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 11/2017, Volume 69, Issue 11, pp. 1437 - 1446
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2009, Volume 361, Issue 5, pp. 455 - 467
Journal Article
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2012, Volume 67, Issue 9, pp. 2213 - 2221
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 06/2018, Volume 18, Issue 6, pp. 615 - 626
Journal Article